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_____________________________________________________________________ 
Abstract  A photolabile precursor of the neuroinhibitory amino acid glycine has 
been synthesised with two phosphate groups attached to the indoline nucleus at a 4-
alkoxy substituent. In common with the photochemical properties of other 1-acyl-7-
nitroindolines, this releases glycine on a sub-s time scale upon irradiation with near-
UV light. The synthetic route previously developed for the preparation of the GABA 
analogue required some modifications because of the greater hydrolytic sensitivity of 
the glycine compound. The phosphorylation method used here could be beneficial to 
the synthesis of other nitroindoline-caged amino acids, especially the related caged 
GABA derivative. Glycine released by laser photolysis on spinal cord neurons 
generated fast-rising responses and the pharmacological properties of the reagent are 
such that it is useful for physiological experiments. 
_____________________________________________________________________ 
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1. Introduction 
The technique of liberating biologically active compounds from photolabile 
precursors, upon brief irradiation with near-UV light is a valuable tool for studies of 
biological processes. The method relies on the availability of suitable reagents, widely 
known as ‘caged’ compounds and their syntheses and applications are described in 
reviews.1 These reagents must satisfy a number of prerequisites such as solubility and 
stability in aqueous media, high purity and pharmacological inertness prior to 
photolysis, rapid and efficient photolysis at neutral pH followed by fast dark reactions 
after photolysis, and no release of toxic by-products after photocleavage. Failure to 
fulfil any one of the above criteria usually renders a caged reagent inadequate for 
application in biological systems. 
 
During the last decade we have produced a number of 7-nitroindoline-caged 
neuroactive amino acids, including L-glutamate 12 and 2,3 -aminobutyrate (GABA) 3 
and glycine 4,4 L-aspartate 5,5 and L-alanine 6,6 which have been applied in various 
biological systems. Detailed pharmacological evaluation has found that caged 
glutamates 1 and 2 do not bind to glutamergic receptors prior to photolysis and are 
therefore suitable reagents for investigations of synaptic transmission.4,5,7 They fulfil 
all the above criteria to a satisfactory extent, they are now commercially available and 
have been extensively applied in neuroscience.8 In contrast, caged GABA 3 and caged 
glycine 4 were found to bind to their respective ionotropic GABA or glycine receptors 
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on neuronal cells prior to photolysis, blunting the response to the photolytically-
released amino acid.4,7 A separate investigation has indicated that neither caged 
glycine 4 nor caged L-aspartate 5 inhibit the NMDA receptor, suggesting that reagent 
4 might have useful application in studies of the effects of co-agonist binding to 
NMDA receptors.5 Photolytic release of L-alanine from 6 has enabled the observation 
of alanine-induced pre-steady-state currents of three different neutral amino acid 
transporters.6 
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Photolysis of these reagents in aqueous solution proceeds with stoichiometric release 
of the amino acid, accompanied by the corresponding nitrosoindole by-product as 
shown in Scheme 1. A study of the photolysis mechanism9 of 1-acyl-7-nitroindolines 
in aqueous solution determined the release rate of the amino acid as ~5  106 s-1 at 
ambient temperature, corresponding to a half-life of ~150 ns which is sufficiently 
rapid for mimicking biological processes. 
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Scheme 1. Photocleavage reaction of 7-nitroindoline-caged amino acids in aqueous 
solution. 
 
The advantageous photochemical properties and hydrolytic stability of 1-acyl-7-
nitroindolines motivated us to seek means of eliminating or at least suppressing the 
adverse pharmacological properties of 3 and we have previously reported the 
synthesis and photochemical evaluation of the modified caged GABA reagent 7.10 
The incorporation of a high concentration of negative charge close to the nitroindoline 
nucleus did not affect its photochemical properties. Furthermore, the structure 
retained the advantages of hydrolytic stability of the cage and its fast and efficient 
photorelease at near-UV and 405 nm wavelengths, but brought about a large reduction 
in the interaction of 7 with GABAA receptors.
11a Further detailed neurophysiological 
investigations11b revealed the existence of a new class of miniature currents 
(“preminis”) in developing interneurons that reflect the activation of presynaptic 
GABAA receptors following random vesicular release. 
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The successful reduction of adverse pharmacological properties of 7 prior to 
photolysis opened the possibility that the same strategy might be applied to the 
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glycine analogue 8. Various caged glycine derivatives have been reported by other 
workers12 but have suffered from problems of instability or inadequate photolytic 
efficiency. We had anticipated that synthesis of the diphosphate nitroindoline (DPNI) 
glycine 8 would closely follow the route described for 7. In the event, a number of 
modifications were required, in part because of greater hydrolytic sensitivity of the 
amide bond in the glycine series of precursors. In addition, the method for 
introduction of the two phosphate groups was substantially improved over that 
previously described in the synthesis of 7. In the course of developing the synthesis, 
we also prepared the 4-methoxy compound 15 and in the process obtained some 
further insight into side reactions that occurred during nitration reactions of N-
acylindolines. 
 
2. Results and discussion 
In our previous investigations10 of a synthetic route to 7, we had found that di-Boc 
protection of the amino group in a GABA precursor had been ineffective in avoiding 
side reactions at this centre, although the same protection strategy had been effective 
for amino groups in precursors to 4-methoxy-7-nitroindoline derivatives of L-
glutamate,13 and L-alanine.6 For the eventual successful synthesis of 7, the problem 
was avoided by masking the amino group as an azide that was converted to an amine 
at a late stage of the synthesis. Nevertheless, in view of the successful application of 
the di-Boc protection strategy for synthesis of L-alanine, we felt it was worthwhile to 
test the same methodology here. Using the 4-methoxy system, the route shown in 
Scheme 2 gave the di-Boc precursor 10. Homogeneous nitration, as used by us 
previously for related nitrations,3b,6,13  gave a mixture in which the major component 
was the N-nitro species 11, isolated as a crystalline solid and characterised by 1H 
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NMR spectroscopy and elemental analysis (see Supplementary data). Although 5- and 
7-mononitro isomers were also present in the reaction products, the substantial 
formation of 11 made this route unacceptable. It now appears that both steric and 
electronic effects are important in the ability of the double Boc protection to limit 
unwanted N-nitration, and we therefore returned to the azide strategy used for 7. 
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Scheme 2. Reagents: (a) NaBH3CNAcOH; (b) EDCHO2CCH2NHBocMeCN; 
(c) (Boc)2OEt3NDMAPCH2Cl2; (d) Cu(NO3)2Ac2OCH2Cl2. 
 
Given the somewhat unpredictable outcome of results with only minor changes in 
structure, we first tested the azide route by preparing the methoxynitroindoline-caged 
glycine 15, as shown in Scheme 3, both to validate the individual steps and to have a 
sample of 15 available for pharmacological testing in comparison with our intended 
target compound 8. Only two points of Scheme 3 deserve specific comment. First, the 
nitration of the azidoacetylindoline 13 was carried out using a minor modification of a 
reported procedure14 (NaNO3 in place of LiNO3) in which scandium triflate acts as a 
catalyst for nitration. In practice, for this substrate there was no advantage in yield or 
regioselectivity over our previous claycop-mediated nitration procedure,3b but the 
scandium triflate procedure was investigated as an alternative because of difficulties 
encountered during the synthesis of 8 (see below) and because we had previously 
found that the claycop procedure was ineffective with indolines bearing a bulky 
substituent at the 4-position.10 The second point of note relates to the Staudinger 
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reduction of the azide 14 that was carried out in aqueous DMF, as had been done at 
the final stage in synthesis of 8. In the latter case the initial product isolated had been 
an iminophosphorane, which required mild but prolonged acid treatment (pH 1 at 
room temperature overnight) to release the required amine.10 In contrast, the reduction 
of 14 under the same conditions gave the amine directly upon work-up of the reaction 
mixture. As discussed below, the susceptibility to hydrolysis of the initial 
iminophosphorane product is remarkably idiosyncratic. 
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Scheme 3. Reagents: (a) NaBH3CNAcOH; (b) EDCBrCH2CO2HMeCN; (c) 
NaN3DMF; (d) NaNO3Ac2OSc(OTf)3MeCN; (e) PPh3aq. DMF. 
 
With preparation of 15 readily achieved, we returned to the synthesis of 8 and, 
following similar methods to those in Scheme 3, readily obtained the azide 19 
(Scheme 4). However, upon very brief alkaline treatment (25 mM NaOH for 2 min) 
which was intended to remove the acetate groups, a mixture of products was detected 
by TLC and UV-vis spectroscopy that indicated significant hydrolysis of the amide 
linkage had taken place. This contrasts with experience in the synthesis of the caged 
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GABA 7, where hydrolysis of the corresponding acetates was readily achieved under 
very similar conditions, without detectable amide hydrolysis. Electron-withdrawal by 
the -azido substituent evidently makes the azidoacetyl amide bond much more 
sensitive to base hydrolysis and we subsequently found that the amide bond was 
~10% hydrolysed at pH 7.0 overnight at room temperature (see details in 
Supplementary Data).  
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Scheme 4. Reagents: (a) NaBH3CNAcOH; (b) EDCBrCH2CO2HMeCN; (c) 
NaN3DMF; (d) Cu(NO3)2Ac2OCH2Cl2 
 
To avoid the problem of amide hydrolysis, we instead carried out the hydrolysis step 
before nitration, since the amide bond in the non-nitrated indoline was expected to be 
much more stable. The diacetate 18 was readily hydrolysed to the diol 20 (Scheme 5) 
and we intended to introduce the two phosphate groups (in protected form) at this 
stage. Phosphorylation of a related diol in the caged GABA synthesis using 
phosphoramidite chemistry had been problematic because of low solubility of the diol 
in THF. A change to dichloromethane solvent with pyridinium trifluoroacetate 
(PyTFA) as the phosphitylation catalyst15 followed by oxidation with MCPBA gave 
the bis(di-tert-butyl phosphate) 21 in excellent yield. Nitration of the protected bis-
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phosphate 21 was complicated by the presence of the acid-sensitive tert-butyl esters, 
which underwent partial deprotection under any of the conditions tried.  After 
numerous trial reactions, it was found that the nitration of diphosphate 21 was best 
achieved with a mixture of acetic anhydride, sodium nitrate and a four-fold excess of 
trichloroacetic acid (relative to the amount of NaNO3). As noted above, partial 
deprotection of the phosphate groups had taken place, indicated by the fact that the 
compound had become water-soluble and behaved as an anion on analytical anion-
exchange HPLC (see Experimental section). Rather than characterise the partially 
deprotected product, although it appeared to be principally a single species, we felt it 
was more convenient to remove the remaining tert-butyl groups but found that prior 
removal of excess nitrate salt from the reaction mixture was required before treatment 
with TFA. Without such removal, treatment of the freeze-dried reaction mixture with 
TFA resulted in an intractable dark mixture, and efforts to quench the excess nitrate 
by addition of reactive electrophiles prior to work up were also ineffective. Thus the 
crude water-soluble reaction mixture was subjected to preparative reverse-phase 
HPLC and the isolated nitroindoline product, after lyophilisation, was successfully 
deprotected with TFA to give 22 in 55% yield. 
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Scheme 5. Reagents: (a) NaOHaq. MeOH; (b) Et2NP(OBut)2PyTFACH2Cl2; 
(c) MCPBA; (d) NaNO3Ac2OCCl3CO2HMeCN; (e) TFA; (f) TCEPaq. DMF 
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With 22 available, completion of the synthesis required only reduction of the azide 
group, but Staudinger reaction using either triphenylphosphine or tri-n-butylphosphine 
in aqueous DMF failed to yield pure 8 even after prolonged mild acidic treatment of 
the reaction mixture. It was evident from HPLC data (not shown) that an 
iminophosphorane was formed, as in the case of the related caged-GABA synthesis,10 
but it was much more resistant to hydrolysis. This was particularly surprising since 
reduction of 14 under the same conditions had given the amine 15 directly upon mild 
acidic work-up (see above), implying ready hydrolysis of the iminophosphorane in 
that case. However, reduction of the azide 22 was successfully accomplished using 
the water-soluble tris(2-carboxyethyl)phosphine hydrochloride (TCEP) to give 8 in 
47% yield after purification by anion-exchange chromatography, precipitation as its 
barium salt and reconversion to the sodium salt. 
 
The photochemistry of both 8 and its model analogue 15 was similar to that of other 
N-acyl-7-nitroindolines. Continuous irradiation of separate solutions of 8 and 15, 
monitored by UV-vis spectroscopy, as described previously,2,3a,10 showed progressive 
decrease of each starting compound and accumulation of the nitrosoindole 
chromophore. Clear isosbestic points were formed as photolysis progressed indicating 
a clean conversion (see Supplementary data). Photolysis of 8 was also monitored by 
HPLC and released glycine was measured by amino acid analysis, as described for 
related compounds.2,3a Glycine recovery was in the range 68-69%. This was 
significantly below the essentially stoichiometric release reported for other 7-
nitroindoline-caged amino acids and appears inconsistent with the clean spectroscopic 
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data for the progressive photolysis but extensive investigations (data not shown) have 
not resolved this matter. 
 
Neurophysiological recordings upon glycine release by near-UV laser photolysis 
Glycine is a major inhibitory fast neurotransmitter in the mammalian spinal cord. To 
test the photorelease of glycine from DPNI-glycine 8 and the effects of 8 itself upon 
neuronal preparations, experiments were done with laser photolysis in spinal cord 
slices prepared from neonatal rats. Whole cell patch clamp recordings were made 
under conditions of high intracellular chloride ion concentration, generating inward 
membrane current in response to activation of glycine receptors by glycine 
photoreleased from 8. The morphology and identity of recorded neurons were 
obtained by epifluorescence imaging of the fluorophore Alexa 488 included in the 
intracellular solution in the whole cell-recording pipette. Photolysis was with laser 
pulses at 405 nm usually of 0.2 ms duration as described previously.11a The laser spot 
diameter was 1 µm in the focal plane and could be directed to the soma or neurites of 
recorded neurons with sub-micron accuracy. The experimental methods are described 
in Supplementary data. 
 
Responses recorded in a motoneuron to concentrations of glycine released at different 
laser intensities in 0.2 ms pulses from DPNI-glycine 8, present at 2 mM, are shown in 
Figure 1A. The amplitude of the response increases with laser intensity (0.4 to 8.1 
mW) up to the point of saturation, as shown in the bar chart of Figure 1D. The 20-
80% rise-times increased from 1.2 ± 0.2 to 2.8 ± 0.5 ms with increasing intensity of 
the pulse. For comparison, the rise time of spontaneous post-synaptic currents (shown 
in Figure 1B) is in the 0.3-1.1 ms range, over a population of 12 cells. As the laser 
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intensity was increased, also the decay time constant increased, from 8.1 ± 0.4 to 28.0 
± 6.1 ms, compared with corresponding values for spontaneous currents of between 
4.2 and 9.1 ms. The slower rise and fall of the responses to photolytically released 
glycine is apparent in the normalised and superimposed traces of Figure 1C. For 
comparison, an average of spontaneous post-synaptic currents is also shown. The 
slower kinetics may be attributed to the larger volume into which glycine is released 
by laser spot photolysis compared with the volume of synaptic release. 
 
 
Figure 1 Responses in spinal motorneurons under whole cell voltage clamp to laser-
evoked photolysis of extracellular 2 mM DPNI-glycine 8 in a 1μm focal spot. 
Negative deflections show inward membrane current due to Cl- ion flux through 
receptor ion channels activated by glycine binding. (A) Increasing intensity of the 
laser pulse (duration 0.2 ms) generates progressively larger amplitudes of response. 
Grey traces are superimposed individual events; black traces are the mean at each 
intensity. Laser power in mW is given at the objective, with 2 mM of 8 present in the 
bath 50% of the light is absorbed by inner filtering. (B) For comparison spontaneous 
glycine synaptic responses and their mean are shown on the same scale. (C) The time 
course of normalised responses to low (light grey), medium and high intensity (black) 
pulses are compared with synaptic responses (dashed line) on the same time-scale. 
The inset shows a time scale expansion of the rise times of the averaged response 
(continuous lines) and of spontaneous events (dashed line). (D, E, F) Summary bar 
charts of data from 12 neurons of the peak amplitude (D), the 20-80% rise-time (E) 
and the exponential time-constant of response decline (F). In panels (E) and (F) the 
left column is data for spontaneous IPSCs due to synaptic glycine release in the same 
neurons, other columns show responses to glycine released by different laser 
intensities.  
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Direct interference between uncaged DPNI-glycine 8 and glycine receptors was tested 
by measuring the amplitude of spontaneous synaptic currents in control and in the 
presence of 3 mM DPNI-glycine. The mean event amplitudes as well as their rise 
times did not change in the two conditions (see Supplementary data Figure S2 and 
text). However, following repetitive uncaging on the same spot, a rundown of the 
light evoked current was consistently observed (Figure S2 and text). The origin of this 
rundown will require further investigations, but it could be associated with the 
observed incomplete stoichiometry obtained on photolysis of DPNI-glycine. 
 
3. Conclusions 
The synthesis of 8 was successfully accomplished but, despite its similarity to the 
previously described caged GABA 7, significant modification of the previously 
established synthetic route was required. The unexpected reactivity of the densely 
functionalised intermediate compounds was surmounted by employing more effective 
reagents and appropriate reaction conditions. The controlled nitration of indolines in 
synthesis of these caged compounds remains subject to a need for individual 
optimisation, while the improved phosphorylation method could usefully be applied to 
a better synthesis of the caged GABA 7.  
 
Release of glycine on spinal cord neurons by localised laser photolysis of 8 showed 
fast activation of glycinergic currents with time-course in the ms range. Although 
slower than glycine mediated synaptic currents recorded in the same neurons, the 
kinetics of activation by photoreleased glycine are nonetheless fast enough to be 
useful in experiments to determine the distribution of glycine sensitivity in neuronal 
compartments and to yield kinetic data of glycine receptor function at synaptic sites in 
situ. A further appealing feature of 8 is that, contrary to the block of GABA (-
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aminobutyric acid) responses seen with the caged GABA analogue DPNI-GABA 7, 
DPNI-gly does not interact with the glycine receptors. The origin of the run-down of 
responses seen with multiple pulses of DPNI-glycine photolysis applied consecutively 
to the same sites was not elucidated in the experiments described here. The present 
synthesis has provided enough material for further pharmacological characterisation 
and these studies will be reported elsewhere in due course. 
 
4. Experimental 
4.1. General 
1H NMR spectra were determined on Varian Inova 600 MHz or Varian Inova 800 
MHz spectrometers in CDCl3 solution with TMS as internal reference, unless 
otherwise specified. Elemental analyses were carried out by MEDAC Ltd., Surrey, 
UK. Electrospray mass spectra were recorded at the School of Pharmacy, University 
of London. Merck 9385 silica gel was used for flash chromatography. Analytical 
HPLC was performed on a 250  4 mm Merck Lichrospher RP8 column or a 125  4 
mm Whatman Partisphere SAX column. Flow rates were 1.5 mL min-1 with either 
column. Preparative HPLC was carried out on a 2  30 cm column (Waters C18 
packing, Cat. No. 20594) at 2 mL min-1 flow rate. Details of mobile phases are given 
at relevant points in the text. Preparative anion-exchange chromatography used a 
column of DEAE-cellulose (2  20 cm). Detection for all analytical and preparative 
chromatography was at 254 nm. Organic solvents were dried over anhydrous Na2SO4 
and evaporated under reduced pressure. Hexanes (bp 40-60 C) were redistilled before 
use. Photolysis experiments were performed in a Rayonet RPR-100 photochemical 
reactor fitted with 16  350 nm lamps.  
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4.2. 1-(2-Bromoacetyl)-4-(1,3-diacetoxypropan-2-yloxy)indoline (17) 
A solution of 4-(1,3-diacetoxypropan-2-yloxy)indoline (2.93 g, 10 mmol; prepared 
from 16 as previously described10) in dry MeCN (70 mL) was treated with 2-
bromoacetic acid (2.08 g, 15 mmol), followed by 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (2.68 g, 14 mmol) and the mixture was stirred at rt 
under nitrogen overnight. The solvent was evaporated and the residue was taken up in 
EtOAc (80 mL), washed with dilute aq. HCl, saturated aq. NaHCO3 and brine, dried 
and evaporated to pale crystals. Recrystallisation (EtOAc–hexanes) followed by flash 
chromatography [EtOAc–hexanes (2:3)] of the mother liquor gave 17 (3.17 g, 77%) 
as white crystals, mp 77-79 C (EtOAc–hexanes); 1H NMR (600 MHz)  7.87 (d, J = 
8.2 Hz, 1H), 7.19 (t, J = 8.2 Hz, 1H), 6.73 (d, J = 8.2 Hz, 1H), 4.71 (quintet, J = 5.2 
Hz, 1H), 4.34 (dd, J = 5.7, 11.9 Hz, 2H), 4.29 (dd, J = 4.9, 11.9 Hz, 2H), 4.21 and 
4.18 (2  t, J = 8.5 Hz, 2H, rotamers), 4.16 (s, 2H), 3.16 (t, J = 8.5 Hz, 2H), 2.07 (s, 
6H). Anal. Calcd for C17H20NO6Br: C, 49.29; H, 4.87; N, 3.38. Found: C, 49.53; H, 
4.67; N, 3.63. 
 
4.3. 1-(2-Azidoacetyl)-4-(1,3-diacetoxypropan-2-yloxy)indoline (18) 
NaN3 (0.97 g, 15 mmol) was added to a solution of 17 (2.07 g, 5 mmol) in dry DMF 
(40 mL) and the mixture was stirred at rt overnight. The solvent was removed under 
reduced pressure and the residue was diluted with EtOAc (70 mL), washed with water 
and brine, dried and evaporated to give 18 as white crystals (1.69 g, 90%), mp 64-65 
C (Et2Ohexanes); 1H NMR (600 MHz)  7.89 (d, J = 8.1 Hz, 1H), 7.19 (t, J = 8.1 
Hz, 1H), 6.72 (d, J = 8.1 Hz, 1H), 4.71 (quintet, J = 5.2 Hz, 1H), 4.34 (dd, J = 5.8, 
11.9 Hz, 2H), 4.29 (dd, J = 4.7, 11.9 Hz, 2H), 4.00 (t, J = 8.2 Hz, 2H), 3.97 (s, 2H), 
3.14 (t, J = 8.2 Hz, 2H), 2.06 (s, 6H). Anal. Calcd for C17H20N4O6: C, 54.25; H, 5.36; 
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N, 14.89. Found: C, 54.29; H, 5.52; N, 14.68. 
 
4.4. 1-(2-Azidoacetyl)-4-(1,3-diacetoxypropan-2-yloxy)-7-nitroindoline (19) 
To a solution of 18 (489 mg, 1.35 mmol) in a mixture of CH2Cl2 (13.5 mL) and acetic 
anhydride (27 mL) was added copper nitrate hemipentahydrate (365 mg, 1.75 mmol) 
and the mixture was stirred at rt overnight. The solution was concentrated and the 
residue was re-evaporated from toluene, diluted with EtOAc (50 mL) and washed 
with saturated aqueous NaHCO3 and brine, dried and evaporated to brown viscous oil. 
Flash chromatography [EtOAchexanes (1:1)], followed by trituration with ether, 
gave 19 (407 mg, 72%) as yellow crystals, mp 90-91 C (EtOAchexanes); 1H NMR 
(800 MHz)  7.80 (d, J = 9.0 Hz, 1H), 6.84 (d, J = 9.0 Hz, 1H), 4.82 (quintet, J = 5.3 
Hz, 1H), 4.36 (dd, J = 5.9, 11.9 Hz, 2H), 4.31 (dd, J = 4.7, 11.9 Hz, 2H), 4.22 (t, J = 
8.1 Hz, 2H), 4.04 (s, 2H), 3.12 (t, J = 8.1 Hz, 2H), 2.07 (s, 6H). Anal. Calcd for 
C17H19N5O8: C, 48.46; H, 4.54; N, 16.61. Found: C, 48.12; H, 4.47; N, 16.37. 
 
4.5. 1-(2-Azidoacetyl)-4-(1,3-dihydroxypropan-2-yloxy)indoline (20) 
A solution of 18 (1.51 g, 4 mmol) in MeOH (80 mL), water (8 mL) and 1 M aq. 
NaOH (9.6 mL, 9.6 mmol) was stirred at rt for 2 min, quenched with 1 M aq. citric 
acid (19.2 mL) and concentrated to ~40 mL. The solution was diluted with water (20 
mL), extracted with EtOAc (3  40 mL) and the combined organic extract was 
washed with saturated aq. NaHCO3 and brine, dried and evaporated to give 20 (1.00 
g, 85%) as white crystals, mp 110-112 C (EtOAchexanes); 1H NMR (800 MHz; 
DMSO-d6)  7.66 (d, J = 8.1 Hz, 1H), 7.13 (t, J = 8.1 Hz, 1H), 6.78 (d, J = 8.1 Hz, 
1H), 4.77 (t, J = 5.5 Hz, 2H), 4.26 (quintet, J = 5.5 Hz, 1H), 4.22 (s, 2H), 4.00 (t, J = 
8.4 Hz, 2H), 3.58-3.61 (m, 2H), 3.33-3.56 (m, 2H), 3.04 (t, J = 8.4 Hz, 2H). Anal. 
 18 
Calcd for C13H16N4O4: C, 53.42; H, 5.52; N, 19.16. Found: C, 53.69; H, 5.61; N, 
18.80.  
 
4.6. 1-(2-Azidoacetyl)-4-[1,3-bis(di-tert-butoxyphosphoryloxy)propan-2-
yloxy]indoline (21) 
A solution of 20 (0.58 g, 2 mmol) in dry CH2Cl2 (60 mL) was treated under nitrogen 
with pyridinium trifluoroacetate (1.16 g, 6 mmol) and di-tert-butyl N,N-
diethylphosphoramidite (93% purity; 1.61 g, 6 mmol) and the mixture was stirred 
under nitrogen at rt for 20 min. The solution was cooled to 0 C and treated dropwise 
with a solution of m-chloroperbenzoic acid (77% peracid; 2.69 g, 12 mmol) in CH2Cl2 
(60 mL). The solution was stirred at 4 C for 45 min, diluted with CH2Cl2 and washed 
successively with 10% aq. Na2S2O5, saturated aq. NaHCO3 and brine, dried and 
evaporated. Flash chromatography (EtOAc) gave 21 (1.19 g, 88%) as white crystals, 
mp 78-80 C (Et2Ohexanes); 1H NMR (600 MHz)  7.87 (d, J = 8.2 Hz, 1H), 7.18 (t, 
J = 8.2 Hz, 1H), 6.75 (d, J = 8.2 Hz, 1H), 4.70 (quintet, J = 4.9 Hz, 1H), 4.18 (d, J = 
5.2 Hz, 2H), 4.17 (d, J = 5.2 Hz, 2H), 3.98 (t, J = 8.4 Hz, 2H), 3.97 (s, 2H), 3.18 (t, J 
= 8.4 Hz, 2H), 1.47 (s, 18H), 1.45 (s, 18H). Anal. Calcd for C29H50N4O10P2: C, 51.47; 
H, 7.45; N, 8.28. Found: C, 51.87; H, 7.591; N, 8.18. 
 
4.7. 1-(2-Azidoacetyl)-4-[1,3-bis(dihydroxyphosphoryloxy)propan-2-yloxy]-7-
nitroindoline (22) 
To a solution of 21 (237 mg, 0.35 mmol) in dry MeCN (3.5 mL) was added acetic 
anhydride (357 mg, 3.5 mmol), sodium nitrate (59.5 mg, 0.7 mmol) and 
trichloroacetic acid (457 mg, 2.8 mmol) and the mixture was stirred under nitrogen at 
rt for 24 h. TLC [MeOHEtOAc (1:19)] confirmed that all starting material was 
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consumed. The reaction mixture was diluted with 200 mM NaOAc, pH 6.0 (70 mL), 
the pH was raised from 4.8 to 5.5 with 1 M aq. NaOH and the solution was washed 
with Et2O (3  50 mL). Analysis of the aqueous phase by reverse phase HPLC 
[mobile phase 25 mM Na phosphate, pH 6.0MeCN (25:1), tR 5.8 min], and by anion-
exchange HPLC [mobile phase 100 mM Na phosphate, pH 6.0MeCN (5:1), tR 5.2 
min], confirmed that all starting material was nitrated but partial deprotection of 
phosphate esters took place. The solution was loaded onto the preparative HPLC 
column, which was pre-equilibrated with 200 mM NaOAc, pH 6.0, and subsequently 
eluted with the same buffer for further 1.5 h. The column was then washed with water 
and the compound began to elute after about 1 h, when the conductivity of the eluate 
had lowered to that of water. The fractions containing the compound were combined, 
concentrated to about 25 mL and lyophilised. The pale yellow residue was dissolved 
in TFA (15 mL) and stirred at rt for 1 h. The solvent was evaporated, the residue was 
dissolved in 25 mM triethylammonium phosphate, pH 6.0 (75 mL) and the pH was 
raised from 2.6 to 6.0 with 1 M aq. NaOH. HPLC analysis as above confirmed full 
deprotection of the phosphate esters. The solution was loaded onto the preparative 
HPLC column, which was pre-equilibrated with 25 mM triethylammonium phosphate, 
pH 6.0, and subsequently eluted with the same buffer for further 1 h. The column was 
then washed with water and the compound began to elute after about 50 min, when 
the conductivity of the eluate had lowered to that of water. Fractions containing the 
compound were analysed by reverse phase HPLC [mobile phase 100 mM Na 
phosphate, pH 6.0MeCN (25:1), tR 3.6 min], and by anion-exchange HPLC [mobile 
phase 100 mM Na phosphate, pH 6.0MeCN (5:1), tR 5.8 min], combined and 
concentrated. The residue was taken up in water (35.5 mL), passed through a 0.2 m 
membrane and quantified by UV-vis spectroscopy to give pure 22 (5.47 mM, 194 
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mol, 55%). An aliquot (0.6 ml) was exchanged to the Na+ salt (Dowex 50, Na+ 
form); 1H NMR (600 MHz, D2O, acetone ref.)  7.85 (d, J = 9.0 Hz, 1H), 7.13 (d, J = 
9.0 Hz, 1H), 4.92 (quintet, J = 4.7 Hz, 1H), 4.37 (s, 2H), 4.25 (t, J = 7.8 Hz, 2H), 4.09 
- 4.17 (m, 4H), 3.23 (t, J = 7.9 Hz, 2H). LRMS (ESI): calcd for (C13H13N5O12P2 + 
3H)-, 496.0, found: 495.9. The remainder of the solution was lyophilised to a pale 
yellow solid and used in the next step. 
 
4.8. 1-(2-Aminoacetyl)-4-[1,3-bis(dihydroxyphosphoryloxy)propan-2-yloxy]-7-
nitroindoline (8) 
A solution of 22 (191 mol) in water (3 mL) was diluted with DMF (27 mL) and 
treated with tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (383 mg, 1.34 
mmol) and the mixture was stirred at rt under nitrogen for 28 h. The solution was 
concentrated under reduced pressure and the residue was diluted with water (50 mL) 
and washed with EtOAc (3  40 mL). Analysis by reverse phase HPLC [mobile phase 
25 mM Na phosphate, pH 6.0MeCN (25:1), tR 1.8 min], and by anion-exchange 
HPLC [mobile phase 100 mM Na phosphate, pH 6MeCN (5:1), 1.5 mL/min, tR 5.2 
min confirmed complete reduction of the azide. The solution was then adjusted to pH 
6.0 with 1 M aq. NaOH and quantified by UV-vis spectroscopy (51 ml, 3.7 mM, 189 
mol). The solution was diluted with water (250 mL) to conductivity 5.3 mS cm-1 and 
subjected to anion-exchange chromatography using a linear gradient formed from 10 
and 500 mM NaOAc, pH 6.0 (each 1000 mL). Fractions containing the product, 
which eluted at ~300 mM NaOAc, were analysed as above, combined (144 mL) and 
quantified by UV spectroscopy (0.678 mM, 98 mol). The solution was concentrated 
to about 4 mL, diluted with water to 8 mL, treated with 2 M Ba(OAc)2 (2 mL) and 
EtOH (4 mL) and allowed to stand at 4 C overnight. The mixture was centrifuged 
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and the supernatant was analysed by UV-vis spectroscopy (9% of original 
concentration, i.e. 91% precipitation). The precipitate was washed with waterEtOH 
(1:1) (5  15 mL) by resuspension and subsequent centrifugation after each wash 
cycle. The final precipitate was dissolved in water (15 mL) and mixed with Dowex 50 
(Na+ form; 4 g) for 2 h. The resin was filtered off, washed with water (20 mL) and the 
combined filtrates were adjusted from pH 8.4 to 6.8 with 1 M aq. HCl. The filtrate 
was passed through a 0.2 m membrane filter, lyophilised and the residue was 
dissolved in water (4 mL) and quantified by UV-vis spectroscopy to give 8 (22.3 mM, 
89 mol, 47%) as the Na+ salt; [containing a small amount of tris(2-
carboxyethyl)phosphine oxide in approximately (4:1) ratio],  1H NMR (500 MHz, 
D2O, acetone ref.)  8.00 and 7.86 (2  d, J = 9.2 Hz, 1H, rotamers), 7.90 and 7.20 (2 
 d, J = 9.2 Hz, 1H, rotamers), 4.89 and 4.55 (2  quintet, J = 5.0 Hz, 1H, rotamers), 
4.27 and 4.21 (2  t, J = 7.9 Hz, 2H, rotamers), 4.14 (s, 2H), 4.00 - 4.07 (m, 4H), 3.47 
and 3.27 (2  t, J = 7.9 Hz, 2H, rotamers). LRMS (ESI): calcd for (C13H16N3O12P2 + 
2H)-, 470.0, found: 470.0. Complete separation from tris(carboxyethyl)phosphine 
oxide was not achieved in the purification, as shown by signals in the 1H NMR 
spectrum at  2.38-2.43 [m, P(O)(CH2CH2CO2)3], 2.09-2.14 [m, 
P(O)(CH2CH2CO2)3], with intensities corresponding to ~20 mol% of the 
concentration of 8. 
 
4.9. Quantitative photolysis and product analysis for (8) 
Separate solutions of 8 (0.47 mM in 25 mM Na phosphate, pH 7.0 containing 5 mM 
dithiothreitol) were irradiated for varying times (20 or 25 s) in 1 mm path length cells 
(Rayonet Photochemical Reactor). The solutions were analysed by anion-exchange 
HPLC (mobile phase as in Section 4.8) and the extent of photolysis of each solution 
 22 
was determined by comparison of peak heights with those of non-irradiated controls. 
Aliquots of the photolysed solutions were also subjected to quantitative amino acid 
analysis. Measured glycine concentrations were 68-69% of the expected values from 
the extent of photolysis and were not affected by the concentration of dithiothreitol. 
The stock solution (20.9 mM) was also subjected to quantitative amino acid analysis 
and the measured free glycine contamination was 0.35%. 
 
In a further experiments, separate solutions of 8 and 15 (0.51 mM) in 25 mM Na 
phosphate, pH 7.0 were irradiated for increasing times (090 s) in a 1-mm path length 
cell and the extent of photolysis was monitored after each irradiation interval by UV-
vis spectroscopy. 
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Supplementary Data 
The experiments described here relate to the synthesis of the model compound 15 
which were carried out as optimisation procedures for the synthesis of our target 
molecule 8. The mild alkaline hydrolysis of compound 19 and details of 
neurophysiological experiments with 8 including interpretation for some of the results 
are also reported here. Compounds are referred to by the numbering system in the 
main text. UV-vis spectra for progressive photolysis of 8 and 15 are also shown. 
 
Experimental Details 
 
Procedures related to Scheme 2. 
 
1-[2-(tert-Butoxycarbonylamino)acetyl]-4-methoxyindoline (9) 
To a solution of 4-methoxyindoline (3.73 g, 25 mmol; prepared as previously 
described1) in dry MeCN (30 mL) was added N-tert-BOC-glycine (4.44 g, 25.3 mmol) 
and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (5.27 g, 27.5 
mmol) and the mixture was stirred under nitrogen at rt overnight. The solvent was 
evaporated and the residue was taken up in EtOAc (80 mL), washed with 1 M aq. 
HCl, aq. NaHCO3 and brine, dried and evaporated to give 9 (6.43 g, 84%) as white 
crystals, mp 146-148 C (EtOAchexanes); 1H NMR (600 MHz)  7.81 (d, J = 8.2 
Hz, 1H), 7.19 (t, J = 8.2 Hz, 1H), 6.61 (d, J = 8.2 Hz, 1H), 5.55 (br s, 1H), 4.03 (s, 
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2H), 4.01 (t, J = 8.5 Hz, 2H), 3.84 (s, 3H), 3.14 (t, J = 8.5 Hz, 2H), 1.47 (s, 9H). 
Anal. Calcd for C16H22N2O4: C, 62.73; H, 7.24; N, 9.14. Found: C, 62.60; H, 7.26; N, 
9.10. 
 
1-[2-(Di-tert-butoxycarbonylamino)acetyl]-4-methoxyindoline (10) 
A solution of 9 (4.60 g, 15 mmol) in a mixture of dry CH2Cl2 (75 mL) and dry Et3N 
(150 mL) was treated with di-tert-butyl dicarbonate (9.82 g, 45 mmol) and DMAP 
(183 mg, 1.5 mmol) and refluxed under nitrogen for 4 h. The solvents were 
evaporated and the residue diluted with EtOAc (80 mL) and washed successively with 
1 M aq. KHSO4, saturated aq. NaHCO3 and brine, dried and evaporated to give 10 
(4.59 g, 75%) as white crystals, mp 176-178 ˚C (EtOAc-hexanes); 1H NMR (600 
MHz)  7.84 (d, J = 8.2 Hz, 1H), 7.16 (t, J = 8.2 Hz, 1H), 6.58 (d, J = 8.2 Hz, 1H), 
4.45 (s, 2H), 4.07 (t, J = 8.2 Hz, 2H), 3.83 (s, 3H), 3.14 (t, J = 8.2 Hz, 2H), 1.51 (s, 
18H). Anal. Calcd forC21H30N2O6: C, 62.05; H, 7.44; N, 6.89. Found: C, 62.21; H, 
7.51; N, 6.80. 
 
1-[2-(tert-Butoxycarbonylnitroamino)acetyl]-4-methoxy-7-nitroindoline (11) 
A solution of 10 (2.03 g, 5 mmol) in a mixture of CH2Cl2 (50 mL) and acetic 
anhydride (75 mL) was treated with copper nitrate hemipentahydrate (1.28 g, 5.5 
mmol) and stirred at rt overnight. The solution was concentrated and the residue was 
re-evaporated from toluene, diluted with EtOAc (50 mL) and washed with saturated 
aq. NaHCO3 and brine, dried and evaporated to give brown viscous oil. The product 
was dissolved in CH2Cl2 (50 mL), treated with 1 M TFA in CH2Cl2 (7.5 mL, 7.5 
mmol) and stirred at rt overnight. The solvent was evaporated and the residue was 
taken up in EtOAc (50 mL), washed with saturated aq. NaHCO3 and brine, dried and 
evaporated to give brown viscous oil. Flash chromatography [EtOAchexanes (2:3)] 
afforded two major products. The first eluted material was a yellow solid which after 
recrystallisation gave 11 (0.297 g, 37%) as pale yellow crystals mp 137-139 C 
(EtOAc-hexanes), 1H NMR (800 MHz)  7.81 (d, J = 9.0 Hz, 1H), 6.68 (d, J = 9.0 Hz, 
1H), 4.87 (s, 2H), 4.32 (t, J = 8.1 Hz, 2H), 3.93 (s, 3H), 3.17 (t, J = 8.1 Hz, 2H), 1.59 
(s, 9H). Anal. Calcd for C16H20N4O8: C, 48.49; H, 5.09; N, 14.13. Found: C, 48.74; 
H, 5.08; N, 14.13. 
The second eluted material and the mother liquor from the first fraction were 
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combined to pale yellow foam (0.49 g). The 1H 
 
NMR spectrum indicated that that 
product was mostly 1-[2-(tert-butoxycarbonylamino)acetyl]-4-methoxy-7-nitro-
indoline contaminated with the 5-nitro isomer but the material was not further 
characterised. 
 
Procedures related to Scheme 3. 
 
1-(2-Bromoacetyl)-4-methoxyindoline (12) 
A solution of 4-methoxyindoline (1.49 g, 10 mmol; prepared as previously described1) 
in dry MeCN (50 mL) was treated with 2-bromoacetic acid (1.67 g, 12 mmol), 
followed by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.11 g, 
11 mmol) and the mixture was stirred at rt under nitrogen overnight. The solvent was 
evaporated and the residue was taken up in EtOAc (50 mL) washed with dilute aq. 
HCl, saturated aq. NaHCO3 and brine, dried and evaporated to pale crystals. 
Recrystallisation (EtOAc–hexanes) followed by flash chromatography [EtOAc–
hexanes (3:7)] of the mother liquor gave 12 (2.28 g, 84%) as white crystals, mp 141-
143 C (EtOAc–hexanes); 1H NMR (800 MHz)  7.83 (d, J = 8.1 Hz, 1H), 7.20 (t, J = 
8.1 Hz, 2H), 6.63 (d, J = 8.1 Hz, 1H), 4.20 and 4.18 (2  t, J = 8.2 Hz, 2H, rotamers), 
4.15 (s, 2H), 3.84 (s, 3H), 3.16 (t, J = 8.2 Hz, 2H). Anal. Calcd for C11H12NO2Br: C, 
48.91; H, 4.48; N, 5.18. Found: C, 48.83; H, 4.52; N, 5.18. 
 
1-(2-Azidoacetyl)-4-methoxyindoline (13) 
To a solution of 12 (2.16 g, 8 mmol) in dry DMF (60 mL) was added NaN3 (1.56 g, 
24 mmol) and the mixture was stirred at rt overnight. The solvent was removed under 
reduced pressure and the residue was diluted with EtOAc (80 mL), washed with water 
and brine, dried and evaporated to give 13 as a white crystals (1.78 g, 96%), mp 149-
151 C (Et2Ohexanes); 1H NMR (600 MHz)  7.86 (d, J = 8.2 Hz, 1H), 7.20 (t, J = 
8.2 Hz, 2H), 6.62 (d, J = 8.2 Hz, 1H), 4.00 (t, J = 8.5 Hz, 2H), 3.97 (s, 2H), 3.84 (s, 
3H), 3.15 (t, J = 8.5 Hz, 2H). Anal. Calcd for C11H12N4O2: C, 56.89; H, 5.21; N, 
24.11. Found: C, 57.14; H, 5.19; N, 24.39. 
 
1-(2-Azidoacetyl)-4-methoxy-7-nitroindoline (14) 
To a solution of 13 (464 mg, 2 mmol) in dry MeCN (20 mL) was added acetic 
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anhydride (2.04 g, 20 mmol), NaNO3 (340 mg, 4 mmol) and scandium triflate
2 (551 
mg, 1.2 mmol). The mixture was stirred at rt for 22 h, diluted with EtOAc (80 mL) 
and washed with saturated aq. NaHCO3 and brine, dried and evaporated. Repeated 
flash chromatography [EtOAc–hexanes (2:3)] gave 14 (416 mg, 75%) as pale crystals, 
mp 124-125 C (EtOAchexanes); 1H NMR (600 MHz)  7.82 (d, J = 9.0 Hz, 1H), 
6.69 (d, J = 9.0 Hz, 1H), 4.21 (t, J = 8.0 Hz, 2H), 4.03 (s, 2H), 3.93 (s, 3H), 3.12 (t, J 
= 8.0 Hz, 2H). Anal. Calcd for C11H11N5O4: C, 47.66; H, 4.00; N, 25.25. Found: C, 
47.66; H, 3.98; N, 25.52. 
 
1-(2-Aminoacetyl)-4-methoxy-7-nitroindoline (15) 
To a solution of 14 (227 mg, 1 mmol) in dry DMF (10 mL) was added water (1.1 mL) 
and triphenylphosphine (1.84 g, 7 mmol) and the mixture stirred at rt overnight. TLC 
(EtOAchexanes (2:3)] indicated that all starting material was consumed. The solvent 
was evaporated under reduced pressure and the residue was dissolved in water (50 
mL), the pH was lowered from 9.5 to 1.3 with 1 M aq. HCl and the solution was 
washed with Et2O (4  40 mL). The aqueous phase was then carefully basified to pH 
10.5 with 1 M aq. NaOH and extracted with CHCl3 (3  30 mL). The combined 
organic phases from the basic extraction were dried and evaporated to give pale 
yellow crystals (180 mg, 64%); 1H NMR (600 MHz, CDCl3)  7.75 (d, J = 9.0 Hz, 
1H), 6.69 (d, J = 9.0 Hz, 1H), 4.17 (t, J = 8.1 Hz, 2H), 3.92 (s, 3H), 3.59 (s, 2H), 3.10 
(t, J = 8.1 Hz, 2H), 1.64 (s, 2H). The material was dissolved in MeOH (8 mL), diluted 
with water (40 mL) and the pH was carefully lowered to 6.68 with 1 M aq. HCl. After 
lyophilisation the residual powder was dissolved in water (20 mL), passed through a 
0.2 m membrane filter and lyophilised again to give 15 (183 mg, 64%) as its 
hydrochloride salt; 
1
H NMR (600 MHz, D2O, acetone ref.)  7.87 (d, J = 9.1 Hz, 1H), 
6.97 (d, J = 9.1 Hz, 1H), 4.26 (t, J = 7.9 Hz, 2H), 4.14 (s, 2H), 3.97 (s, 3H), 3.15 (t, J 
= 7.9 Hz, 2H). HRMS (ES): Calcd for (C11H13N3O4 + H)
+, 252.0984. Found, 
252.0979. 
 
Procedure related to Scheme 4 
 
Alkaline hydrolysis of 19 
A solution of 19 (274 mg, 0.65 mmol) in MeOH (50 mL), water (5 mL) and 1 M aq. 
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NaOH (1.56 mL, 1.56 mmol) was stirred at rt for 2 min, quenched with 1 M citric acid 
(3.3 mL) and concentrated to ~10 mL. The solution was diluted with water (20 mL), 
washed with EtOAc (3  30 mL) and the combined organic washings were washed 
with saturated aq. NaHCO3 and brine, dried and evaporated to a brown viscous oil 
(292 mg) TLC [MeOHEtOAc (1:24)] and UV-vis spectroscopy showed evidence 
that in addition to hydrolysis of the acetyl groups, amide bond hydrolysis to the 
corresponding nitroindoline, also took place. The latter process was apparent from the 
appearance of a new absorption band at 425 nm. For comparison, 4-methoxy-7-
nitroindoline has max [EtOH25 mM Na phosphate, pH 7.0 (1:24)]/nm (/M-1cm-1) 
247 (11940), 317 (9450), 425 (4200). 
 
In a separate experiment a solution 19 (24.4 mg, 58 mol) in redistilled DMSO (3 
mL) was diluted with 25 mM Na phosphate buffer, pH 7.0 (27 mL) and stirred at rt 
for 23 h. The solution was extracted with EtOAc (3 x 20 mL) and the combined 
organic phases were dried and evaporated, dissolved in EtOH (10 mL) and diluted 
with water (20 mL). UV-vis spectroscopy (max 425 nm) detected ~ 10% amide bond 
hydrolysis. 
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Progressive photolysis spectra for compounds (8) and (15).  
 
 
Figure S1. Panels (A) and (B) are spectra recorded after the irradiation times 
shown in the key of each panel for solutions of 8 and 15 respectively, under 
conditions as specified in the main text. 
Experimental details relating to these spectra appear in the main text. 
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Neurophysiological experiments and photolysis of DPNI-glycine (8) 
 
Sprague-Dawley rats 9 days old were anaesthetised and decapitated in accordance 
with Institutional guidelines. Rats were provided by Janvier (Sterthevin, France) and 
subsequently housed at the central animal house at Université Paris Descartes (Centre 
St Pères, approval number A-750607), approved by the Prefecture de Police following 
inspection by Veterinary Services of the City of Paris, and representatives of the 
French Ministry for Research and the Ministry for Health, in agreement with the 
European Directive 86/609/EEC regarding the protection of animals used for 
experimental and other scientific purposes. Experimental procedures were approved 
by the Directorate of Paris Veterinary Services, by the scientific committee of the 
central animal house of Université Paris Descartes (Centre St Pères) as well as by the 
ethical committee for animal experimentation of Université Paris Descartes. 
A ventral laminectomy was performed in ice-cold solution and mid-thoracic to lumbar 
segments of the cord were extracted, cleared of connective tissue and glued to an agar 
block with tissue glue (Vetbond; WPI Scientific Instruments). The block was fixed 
vertically on the platform of a vibratome, and transverse slices were cut at a thickness 
of 350 µm from the lower lumbar region (L2–L5 segments). The slicing solution was 
kept ice-cold and contained (in mM): 130 K-gluconate, 15 KCl, 0.05 EGTA, 20 
HEPES, and 25 glucose, pH adjusted to 7.4 with NaOH. Kynurenic acid (3 mM) was 
added to the slicing solution to protect the tissue from glutamate excitotoxicity. 
 
Electrophysiological recordings 
 
To minimise usage of the DPNI-glycine, uncaging was done in HEPES-buffered 
saline without solution flow in the bath. Composition (mM) 135 NaCl, 4 KCl, 2 
NaHCO3, 25 glucose, 2 CaCl2, 2 MgCl2 and 10 HEPES, pH 7.4. 2 mM NaHCO3 was 
present to help maintain intracellular pH. TTX 0.2 or 0.5 M, CNQX or NBQX 2 M 
and AP5 20 M were added to block excitation and ionotropic glutamate receptors. 
Slices were transferred to a 0.5 mL recording chamber in HEPES-buffered saline and 
initially perfused at a flow rate of 1.5mL/min. O2 was blown over the surface of the 
bath to improve tissue survival and facilitate mixing. DPNI-glycine 8 was added from 
20 mM stock solutions once a recording was obtained and the solution flow stopped. 
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Drugs were obtained from Tocris (Bristol, U.K.) and chemicals from Sigma (Poole, 
U.K.). 
The cells were recorded in the whole-cell configuration of the patch clamp technique, 
with an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) at room 
temperature. Pipettes were pulled from thick-walled borosilicate glass (GC150F; 
Harvard Apparatus) and fire polished to a final resistance of 1–1.5 M. Internal 
solution contained (in mM): 140 CsCl, 4 NaCl, 1 MgCl2, 0.5 CaCl2, 5 EGTA, 10 
HEPES, 2 MgATP, 3 mM QX-314 (lidocaine N-ethyl bromide), pH 7.3. Alexa 488 
(20 or 40 µM) was included to obtain cell morphology. Series resistance (between 4 
and 10 M) was monitored by applying 20 ms long hyperpolarizing pulses and it was 
compensated by 60-80%. The experiment was abandoned if series resistance 
increased by more than 20%. Given the typical motoneuron whole cell capacitance of 
approximately 200 pF, this corresponds to a corner frequency between 0.2 and 0.8 
kHz. 
Data acquisition was with a P1401 interface (CED Cambridge UK) and WinWCP 
software (written by Dr John Dempster, University of Strathclyde). 
 
Laser-induced photorelease of glycine from DPNI-glycine. 
 
The custom experimental microscope used for photolysis of DPNI-glycine 8 has 
been described in full.3 Briefly, the collimated output of a 405 nm fiber-coupled 
laser (Iflex 2000, Point Source, Southampton, UK) was expanded to 90% of the 
back aperture of a 63, 0.9 NA Leica water-dipping objective. The point spread 
function of the laser at the focus had a Gaussian profile, with 1/e2 radius = 0.57 
µm in the focal plane and 1.9 µm axially. The light pulse entering the objective 
was monitored with a photodiode and recorded. The frequency, duration and 
intensity of laser pulses were set with a Digitimer D4030 (Digitimer, Welwyn, 
UK) and analogue electronics. Transmitted illumination was with a white LED 
through a 0.9 NA darkfield condenser. Epifluorescence illumination was with a 
blue LED (excitation 470/30 nm). Light emitted from Alexa 488 was filtered 
530/40 nm, collected by an EMCCD camera (Andor Ixon, Belfast, UK) and 
images were acquired with Andor software. Once the cell was filled and a 
dendritic field selected, the solution flow was turned off, DPNI-glycine was added 
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directly to the bath to give concentrations up to 3 mM and after mixing was 
allowed to equilibrate for at least 5 min before photolysis. Laser flashes were 
usually of 200 µs duration, repeated at up to 0.2 Hz and with intensities at the 
preparation up to 2 mW. 
 
Interactions between DPNI-glycine and glycine receptors 
 
The possibility that DPNI-glycine 8 might itself interfere with glycine synaptic 
transmission was tested by comparing the amplitude of spontaneous glycinergic 
synaptic events in the absence of 8 or its presence in the bath at 3 mM concentration. 
An example of spontaneous glycinergic currents before and during application of 3 
mM DPNI-glycine is shown in Figure S2A and S2B respectively. There is no 
difference in the average amplitude of synaptic response with or without DPNI-
glycine  (from 89 ± 17 to 87 ± 17 pA, n = 12 cells, Figure S2D). Similarly, the rise-
time is not affected by the presence of the caged compound (1.1 ± 0.1 and 1.2 ± 0.1 
ms, n = 12, Figure S2C), indicating that there is very little interaction between glycine 
receptors and the caged glycine before photolysis. 
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Figure S2. Testing for interference of photolysis of DPNI-glycine 8 with glycine 
receptors. (A-D) 3 mM DPNI-glycine has no effect on synaptic responses. (A) 
Superimposed spontaneous glycine synaptic responses and the mean before addition 
of DPNI-glycine. (B) Superimposed records on the same scale in the presence of 3 
mM DPNI-glycine. (C, D) Data from 12 neurons showing no systematic effect of 3 
mM DPNI-glycine on the 20-80% rise-time (C) or amplitude (D) of spontaneous 
glycine synaptic responses. (E-G) Repeated photolysis pulses at the same location. (E, 
F) Progressive decrease in the response amplitude during 45 responses to 1 ms pulses 
of 4.8 mW at 0.2 Hz superimposed (E) and plotted against pulse number (F). (G) Data 
obtained in a similar experiment with briefer (0.2 ms) higher intensity pulses (7.2 mW 
at the objective) showing approx. 20% rundown. Both pulse protocols produce 
maximal photolysis of DPNI-glycine. 
 
Repeated photorelease at the same location resulted in a progressive decrease of the 
peak amplitude of glycine-evoked currents. The run down was very severe for long (1 
ms, 4.8 mW) pulses, as shown in Figure S2E, where 45 consecutive responses 
progressively decreased in size to ~40% of the starting value (Figure S2F). The effect 
is less pronounced when 200 µs pulses (7.2 mW) are used, as shown by the ~20% run 
down after 20 pulses (Figure S2G, average of 12 experiments), but was present for all 
intensities and pulse durations tested. The laser pulses had sufficient energy to 
produce complete photolysis of DPNI-glycine in the irradiated volume. Experiments 
to test the origin of the rundown suggested that it was due to the photolysis reaction of 
DPNI-glycine. It could not be attributed to the presence of residual tris(2-
carboxyethyl)phosphine oxide present in the solution (see Experimental section 4.8), 
and was unaffected by adding ascorbate or glutathione to scavenge reactive by-
products (data not shown). Similar rundown has not been seen previously with 
nitroindoline-caged amino acids, neither with MNI-glutamate nor DPNI-GABA. Its 
origin may be associated with the 68-69% glycine release obtained on photolysis of 
DPNI-glycine, contrasting with the full stoichiometric conversions of MNI-glutamate4 
and DPNI-GABA5 reported previously. 
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